Page last updated: 2024-09-05

sb 203580 and iodoresiniferatoxin

sb 203580 has been researched along with iodoresiniferatoxin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(iodoresiniferatoxin)
Trials
(iodoresiniferatoxin)
Recent Studies (post-2010) (iodoresiniferatoxin)
3,48941,13768017

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)iodoresiniferatoxin (IC50)
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)4
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)4
Transient receptor potential cation channel subfamily V member 4Rattus norvegicus (Norway rat)4
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Hashim, AZ; Jaffal, SM1

Other Studies

1 other study(ies) available for sb 203580 and iodoresiniferatoxin

ArticleYear
Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms.
    Thorax, 2009, Volume: 64, Issue:9

    Topics: Airway Obstruction; Animals; Carbazoles; Citric Acid; Cough; Diterpenes; Enzyme Inhibitors; Female; Guinea Pigs; Imidazoles; Indole Alkaloids; Male; Nerve Growth Factors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptor, trkA; TRPV Cation Channels

2009